Here are four insights:
1. The increasing number of degenerative spine condition cases as well as a growing aging population will boost the artificial disc replacement market.
2. The demand for minimally invasive procedures over traditional fusions will also boost market growth.
3. Artificial discs’ costliness as well as unfavorable reimbursements will hinder market growth, however.
4. Key market players include Alphatec Spine, Medtronic, DePuy Synthes, Stryker, Smith & Nephew, Orthovita, Globus Medical, Zimmer Biomet, Aesculap Implant Systems and NuVasive.
More articles on devices:
Stryker, Zimmer Biomet, SeaSpine & more: 24 device company key notes
North America dominates pedicle screw systems market: 3 observations
SeaSpine ranks 3rd among top NASDAQ medical device stocks for first half of 2017 — 5 insights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
